WebFounded. 1996. Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines … WebJan 31, 2024 · Contacts: Nicole Arndt, Investor Relations [email protected] 510-665-7264 Derek Cole, President Investor Relations Advisory Solutions [email protected] SOURCE Dynavax Technologies...
Dynavax Announces Uplisting to the Nasdaq Global Select Market
WebInvestor Relations Our vision and work ethic are guided by the collective ideals underpinning Our Values, and these form the basis of our company culture. Corporate Overview … Investor Contact; Stock Information Stock Quote. Change Volume Today's Open … Investor Relations Dynavax Technologies Corporation Investor Contact; Corporate Governance Corporate Governance. The Board of … The Investor Relations website contains information about Dynavax Technologies … Investor Relations [email protected]. Footer Links - Column 1. About; Overview; … Dynavax Technologies Corporation is followed by the analysts listed above. … Before joining Dynavax, he held leadership roles in investor relations, … WebAug 7, 2024 · Dynavax Technologies (DVAX-0.62%) Q2 2024 Earnings Call Aug 06, 2024, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator china fixed asset investment 2021
Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call ...
WebMar 10, 2024 · Review quarterly and annual revenue, net income, and cash flow for Dynavax Technologies Corp (DVAX:XNAS) stock through the last fiscal year. WebNov 6, 2024 · Nicole Arndt-- Senior Manager, Investor Relations. Ryan Spencer-- Chief Executive Officer. Michael Ostrach-- Chief Financial Officer. More DVAX analysis. All … WebAug 7, 2024 · Dynavax Technologies Corporation (NASDAQ:NASDAQ:DVAX) Q2 2024 Results Conference Call August 7, 2024 4:30 PM ETCompany ParticipantsHeather Rowe - … china fixed asset investment